Taro Pharmaceutical Industries (TARO) Reports Improved Q2 EPS of $1.46
Get Alerts TARO Hot Sheet
Join SI Premium – FREE
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) reported Q2 EPS of $1.46, versus $1.32 reported last year. Revenue for the quarter came in at $160.97 million, versus $138.25 million reported last year.
For earnings history and earnings-related data on Taro Pharmaceutical Industries Ltd. (TARO) click here.
For earnings history and earnings-related data on Taro Pharmaceutical Industries Ltd. (TARO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Union Pacific (UNP) Tops Q1 EPS by 18c
- PHINIA Inc. (PHIN) Reports Q1 EPS of $1.08, provides guidance
- Southern Copper Corp. (SCCO) Tops Q1 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!